Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 14;34(1):e1563.
doi: 10.1590/0102-672020210001e1563. eCollection 2021.

BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 2): UPDATE ON TREATMENT

[Article in English, Portuguese]
Leandro Cardoso Barchi  1   2 Marcus Fernando Kodama Pertille Ramos  1 André Roncon Dias  1 Nora Manoukian Forones  3 Marineide Prudêncio de Carvalho  3 Osvaldo Antonio Prado Castro  3 Paulo Kassab  3 Wilson Luiz da Costa-Júnior  4   5 Antônio Carlos Weston  6 Bruno Zilberstein  1   2 ConsensoÁlvaro Antônio Bandeira FerrazAmir ZeideCharrufAndré BrandaliseAndré Maciel da SilvaBarlon AlvesCarlos Augusto Martinez MarinsCarlos Alberto MalheirosCelso Vieira LeiteClaudio José Caldas BrescianiDaniel SzorDonato Roberto MucerinoDurval R WohnrathElias JirjossIliasEuclides Dias Martins FilhoFabio PinatelLopassoFelipe José Fernandez CoimbraFernando E Cruz FelippeFlávio Daniel Saavedra TomasischFlavio Roberto TakedaGeraldo IshakGustavo Andreazza LaporteHerbeth José Toledo SilvaIvan CecconelloJoaquim José Gama RodriguesJosé Carlos Del GrandeLaércio Gomes LourençoLeonardo Milhomem da MottaLeonardo Rocha FerrazLuis Fernando MoreiraLuis Roberto LopesMarcelo Garcia TonetoMarcelo MesterMarco Antônio Gonçalves RodriguesMaurice Youssef FrancissNelson AdamiAndreolloOly Campos CorlettaOsmar Kenji YagiOsvaldo MalafaiaPaulo Pimentel AssumpçãoPaulo Roberto Savassi-RochaRamiro Colleoni NetoRodrigo Jose de OliveiraRubens Antonio AissarSallunRui WeschenfelderSaint Clair Vieira de OliveiraThiago Boechat de AbreuTiago Biachi de CastriaUlysses Ribeiro JuniorWilliams BarraWilson Rodrigues de Freitas Júnior
Affiliations
Review

BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 2): UPDATE ON TREATMENT

[Article in English, Portuguese]
Leandro Cardoso Barchi et al. Arq Bras Cir Dig. .

Abstract

Background: : The II Brazilian Consensus on Gastric Cancer of the Brazilian Gastric Cancer Association BGCA (Part 1) was recently published. On this occasion, countless specialists working in the treatment of this disease expressed their opinion in the face of the statements presented.

Aim: : To present the BGCA Guidelines (Part 2) regarding indications for surgical treatment, operative techniques, extension of resection and multimodal treatment.

Methods: To formulate these guidelines, the authors carried out an extensive and current review regarding each declaration present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases initially with the following descriptors: gastric cancer, gastrectomy, lymphadenectomy, multimodal treatment. In addition, each statement was classified according to the level of evidence and degree of recommendation.

Results: : Of the 43 statements present in this study, 11 (25,6%) were classified with level of evidence A, 20 (46,5%) B and 12 (27,9%) C. Regarding the degree of recommendation, 18 (41,9%) statements obtained grade of recommendation 1, 14 (32,6%) 2a, 10 (23,3%) 2b e one (2,3%) 3.

Conclusion: : The guidelines complement of the guidelines presented here allows surgeons and oncologists who work to combat gastric cancer to offer the best possible treatment, according to the local conditions available.

Objetivo:: O II Consenso Brasileiro de Câncer Gástrico da Associação Brasileira de Câncer Gástrico ABCG (Parte 1) foi recentemente publicado. Nesta ocasião inúmeros especialistas que atuam no tratamento desta doença expressaram suas opiniões diante declarações apresentadas.

Apresentar as Diretrizes da ABCG (Parte 2) quanto às indicações de tratamento cirúrgico, técnicas operatórias, extensão de ressecção e terapia combinada.

Métodos:: Para formulação destas diretrizes os autores realizaram extensa e atual revisão referente a cada declaração presente no II Consenso, utilizando as bases Medline/PubMed, Cochrane Library e SciELO, inicialmente com os seguintes descritores: câncer gástrico, gastrectomia, linfadenectomia, terapia combinada. Ainda, cada declaração foi classificada de acordo com o nível de evidência e grau de recomendação.

Resultados:: Das 43 declarações presentes neste estudo, 11 (25,6%) foram classificadas com nível de evidência A, 20 (46,5%) B e 12 (27,9%) C. Quanto ao grau de recomendação, 18 (41,9%) declarações obtiveram grau de recomendação 1, 14 (32,6%) 2a, 10 (23,3%) 2b e um (2,3%) 3.

Conclusão:: O complemento das diretrizes aqui presentes possibilita que cirurgiões e oncologistas que atuam no combate ao câncer gástrico possam oferecer o melhor tratamento possível, de acordo com as condições locais disponíveis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none

References

    1. Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4) a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–1957. - PubMed
    1. Association JGC. Japanese gastric cancer treatment guidelines 2018 (5th edition) Gastric Cancer; 2020. - PMC - PubMed
    1. Bang YJ, Kang YK, Catenacci DV, Muro K, Fuchs CS, Geva R. Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma results from the phase II nonrandomized KEYNOTE-059 study. Gastric Cancer. 2019;22(4):828–837. - PMC - PubMed
    1. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA) a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–697. - PubMed
    1. Barchi LC, Ramos MFKP, Dias AR, et al. II Brazilian Consensus on Gastric Cancer by the Brazilian Gastric Cancer Association. Arq Bras Cir Dig. 2020 doi: 10.1590/0102-672020190001e1514.. - DOI - PMC - PubMed